ArticleHaematologica2014

A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells.

Marleen M van Loenen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.